HUMAN API PORTFOLIO
Human Active Pharmaceutical Ingredients
Explore our comprehensive portfolio of 20 therapeutic categories spanning 245+ curated APIs. All sourced from WHO-GMP-certified manufacturing units with complete regulatory documentation support.
20
Categories
245+
APIs Listed
WHO
GMP Certified
11 APIs
Steroids
Synthetic glucocorticoid APIs spanning topical, inhaled, injectable, and systemic formulation grades. Supplied in USP/EP/BP specification to pharmaceutical manufacturers across regulated and emerging export markets.
12 APIs
Anti Malarials
Artemisinin derivatives, quinoline alkaloids, and cinchona-based APIs for ACT and parenteral malaria regimens. Supplied in USP/EP/BP grade to manufacturers serving endemic and non-endemic export markets.
12 APIs
Anti Hypertensive
ACE inhibitors, angiotensin receptor blockers, and calcium channel antagonists for blood pressure regulation. Supplied in USP/EP/BP grade for oral solid-dose manufacturing across global cardiovascular product lines.
11 APIs
Anti Retroviral
Nucleoside, non-nucleoside, and protease-inhibitor APIs targeting HIV replication cycles. Supplied in USP/EP/BP grade for fixed-dose combination ART manufacturing across global health procurement channels.
13 APIs
Vitamins
Water-soluble and fat-soluble vitamin APIs, plus active vitamin D analogues, in pharmaceutical grade. Supplied for multivitamin, nutraceutical, and deficiency-correction formulation manufacturing.
13 APIs
Anti Cancer
Cytotoxic agents, targeted kinase inhibitors, antimetabolites, and hormone-pathway APIs for oncology and oncology-adjacent indications. Supplied in pharmaceutical grade for IV, oral, and topical formulation manufacturing.
7 APIs
Macrolides
Broad-spectrum macrolide antibiotics with unique tissue penetration and intracellular accumulation profiles. Active against atypical organisms, respiratory, and STI-associated pathogens.
8 APIs
Anti Diabetic
Biguanides, sulfonylureas, thiazolidinediones, and alpha-glucosidase inhibitors for glycaemic control. Supplied in USP/EP/BP/IP grade for oral solid-dose manufacturing across Type 2 diabetes product lines.
7 APIs
Anti-Inflammatory / Analgesic
NSAIDs, COX inhibitors, and non-NSAID analgesics for pain and inflammation management. Supplied in USP/EP/BP/IP grade for tablet, injectable, and topical formulation manufacturing.
5 APIs
Anti Tuberculosis
First and second-line TB APIs targeting Mycobacterium tuberculosis bactericidal pathways. Supplied in USP/EP/BP/IP grade for DOTS and drug-resistant tuberculosis combination therapy manufacturing.
6 APIs
Anti Ulcerants
Proton pump inhibitors supplied as raw powder and enteric-coated pellet intermediates, plus H2 blockers, in USP/EP grade for capsule and tablet formulation manufacturing across global GI product lines.
6 APIs
Anti Asthmatic
Xanthine bronchodilators and beta-2 agonists managing airway obstruction. Supplied in USP/EP/BP grade for tablet, injectable, and nebuliser formulation manufacturing across asthma and COPD product lines.
6 APIs
Anti Convulsant
Sodium channel blockers and GABAergic agents controlling seizure threshold and frequency. Supplied in USP/EP/BP/IP grade for oral solid-dose manufacturing across epilepsy and neuropathic pain product lines.
5 APIs
Anti Protozoal
Nitroimidazole and thiazolide APIs targeting anaerobic protozoan infections. Supplied in USP/EP/BP grade for oral tablet, suspension, and microgranule formulation manufacturing across global GI/parasitology product lines.
6 APIs
Anti-Fungal
Azole, allylamine, and fungistatic antibiotic APIs disrupting fungal cell membrane synthesis. Supplied in USP/EP/BP/IP grade for topical, oral, and vaginal formulation manufacturing across dermatology product lines.
12 APIs
Anti-Histamine
H1 receptor antagonists and allergy-adjacent APIs blocking histamine-mediated inflammatory cascades. Supplied in USP/EP/BP grade for tablet, syrup, and injectable formulation manufacturing across allergy product lines.
10 APIs
Anti-Depressant
SSRI, SNRI, tricyclic, and MAOI-class APIs modulating serotonin and norepinephrine neurotransmission. Supplied in USP/EP/BP grade for oral tablet manufacturing across mood-disorder product lines.
13 APIs
Hormones
Steroidal progestogens, androgens, and reproductive biologics for endocrine regulation and fertility therapy. Supplied in pharmaceutical grade for injectable, oral, and topical formulation manufacturing.
38 APIs
Antibiotics / Antibacterial
Penicillins, cephalosporins, fluoroquinolones, aminoglycosides, and glycopeptides — including beta-lactamase inhibitor combinations — for bacterial infection management. Supplied in USP/EP/BP grade for oral and sterile injectable formulation manufacturing.
44 APIs
General
Broad-spectrum APIs spanning CNS, cardiovascular, urology, and metabolic indications — plus enzyme and biologic preparations. Supplied in pharmaceutical grade for diverse formulation manufacturing across primary and specialty care product lines.
⚗️ 🔬
Complete Regulatory Documentation
Every API in our human portfolio comes with full COA, stability data per ICH guidelines, US-DMF / EU-CEP dossier assistance, and WHO-GMP certified manufacturing traceability.
USFDA DMF Support
EU-CEP Compliance
WHO-GMP Certified
ICH Stability Data
Request API Portfolio Brochure →
BRIXCELL LIFESCIENCES PVT LTD 